RGLS

Regulus Therapeutics

Delisted

RGLS was delisted on the 24th of June, 2025.

27 hedge funds and large institutions have $12.6M invested in Regulus Therapeutics in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 16 closing their positions.

Holders
27
Holders Change
-9
Holders Change %
-25%
% of All Funds
0.46%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
8
Reduced
10
Closed
16
Calls
$1.28M
Puts
Net Calls
+$1.28M
Net Calls Change
+$1.09M
Name Market Value Shares Shares
Change
Shares
Change %
T. Rowe Price Associates
26
T. Rowe Price Associates
Maryland
-18,460 Closed
Two Sigma Advisers
27
Two Sigma Advisers
New York
-17,050 Closed
Two Sigma Investments
28
Two Sigma Investments
New York
-11,444 Closed
GC
29
Grimes & Company
Massachusetts
-8,820 Closed
Jane Street
30
Jane Street
New York
-7,364 Closed
WA
31
WealthTrust Axiom
Pennsylvania
-6,800 Closed
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
-6,583 Closed
Lido Advisors
33
Lido Advisors
California
-5,450 Closed
Millennium Management
34
Millennium Management
New York
-4,889 Closed
GFS
35
GYL Financial Synergies
Connecticut
-3,400 Closed
MIG
36
McGuire Investment Group
Rhode Island
-1,500 Closed
ATFA
37
All Terrain Financial Advisors
Minnesota
-1,500 Closed
DY
38
Dowling & Yahnke
California
-1,200 Closed
Creative Planning
39
Creative Planning
Kansas
-1,200 Closed
William Blair & Company
40
William Blair & Company
Illinois
-1,120 Closed
EWM
41
Endurance Wealth Management
Rhode Island
-675 Closed
HWM
42
HighMark Wealth Management
Minnesota
Fidelity Investments
43
Fidelity Investments
Massachusetts
CFGS
44
Concourse Financial Group Securities
Alabama
CFD
45
Creative Financial Designs
Indiana
Wolverine Trading
46
Wolverine Trading
Illinois
Rockefeller Capital Management
47
Rockefeller Capital Management
New York
$0 1 +1 New
Citigroup
48
Citigroup
New York
$0 8 +8 New